'Omics' in Chronic Liver Disease

Description

The 'omics' revolution offers a gateway to a new level of precision medicine in chronic liver disease.  In this session, we highlight  six outstanding examples of genomic and metabolic explorations into the pathogenesis and diagnosis of HCC and MASLD.

Objectives

  • Discuss genomic advances impacting our understanding of the mechanisms of hepatocarinogenesis.
  • Identify novel targets for future therapeutic interventions in hepato-biliary cancers.
  • Recognize new metabolic pathways involved in MASLD.